STING1 and chronic obstructive pulmonary disease: Therefore, in this study, using fibroblasts from smoker COPD patients and healthy subjects, we investigated the activation status of STING/IFN-I pathway and the rationale behind using pharmacological inhibition of STING as a potential adjuvant to enhance the anti-inflammatory effects of commonly used corticosteroids.